ENTITY

Zhejiang Hisun Pharmaceutical Co, Ltd. (600267 CH)

33
Analysis
Health Care • China
Zhejiang Hisun Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical products. The Company's products include anti-tumor, anti-parasite, cardiovascular, and anti-infection drugs.
more
bullish•FUJIFILM Holdings
•18 Mar 2020 13:32

Fujifilm’s Shares Hit Daily Upper Limit on COVID Trial Drug Boost

Fujifilm Holdings’ shares hit its daily upper limit in the early hours of today’s trading at Tokyo Stock Exchange driven by news that the company...

Share
•21 Aug 2019 02:46

Shanghai Henlius Biotech IPO Initiation: Going Large

Shanghai Henlius Biotech (1566213D HK) is a biopharmaceutical company and a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group)...

Logo
840 Views
Share
•19 Feb 2019 01:24

HLX02: Innovation Could Overtake

The oncology treatment landscape in China is evolving rapidly as the government has prioritized access to innovative drugs to meet this significant...

Share
•06 Oct 2016 21:27

Falling Fertility Adds to China's Population Woes

By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...

Logo
4.2k Views
Share
•12 Sep 2016 23:18

Iran Shows China the Way on Population Expansion

Faced with dramatically falling birth rates, Iran has introduced a wide range of pro-natalist policies. In contrast, China has been half-hearted in...

Logo
298 Views
Share
x